SCHEMBL22421168

SCHEMBL22421168

CONc1cnn2c1C(=O)N(Cc1ccccc1)CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAP3K14 Q99558 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ KAT2B Q92831 6/20 0.39
▸ PKM P14618 1/20 0.39
▸ KCNH2 Q12809 1/20 0.38
▸ GRM2 Q14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22421129 0.79 MAP3K14 (0.40) NPC1LMNARAB9AALDH1A1KDM4E
SCHEMBL20939799 0.77 NPC1 (0.49) NPC1LMNARAB9AALDH1A1KDM4E
SCHEMBL22421167 0.73 RAB9A (0.46) NPC1LMNARAB9AALDH1A1KDM4E
SCHEMBL11052192 0.69 KMT2A (0.59) ALDH1A1HPGDPOLBGAAKCNH2
SCHEMBL22421149 0.68 MAP3K14 (0.39) MAP3K14KAT2B
SCHEMBL10913751 0.66 KMT2A (0.54) NPC1LMNARAB9AKDM4EHPGD
SCHEMBL14107110 0.66 LMNA (0.46) NPC1LMNARAB9AALDH1A1KDM4E
SCHEMBL23607688 0.65 KMT2A (0.51) HTTPOLBKCNH2GRM2CYP2C19
SCHEMBL12233149 0.64 POLB (0.53) LMNAALDH1A1POLBGAASMN1; SMN2
SCHEMBL1101970 0.64 KMT2A (0.50) KDM4EHPGDPOLBKCNH2GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478673-B1 CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-09-16 — — EP disclosed
Send feedback